13F reference period
Q2 2026
Security Snapshot
BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA) Institutional Ownership
CUSIP: 09060U606
13F Institutional Holders and Ownership History from Q2 2024 to Q3 2026
Institutions Reporting
21
Shares (Excl. Options)
1.33M
Full value: 1,333,351 · shares · 30 Jun 2026Price
$1.24
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- BCDA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,333,351
- Total 13F value
- $1,646,986
- Portfolio coverage rank
- 0%
- Share change
- +644,906
- Value change
- +$795,557
- Number of holders
- 21
- Shares outstanding
- 11,165,912
- SEC-reported price per share
- $1.09
- Insider filing price
- $1.09
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- BCDA - BioCardia, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 09060U606.
- 21 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 18 to 21 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$831.14K
Full value: $831,135 · USD · 31 Mar 2026.$1.65M
Full value: $1,646,986 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 21 institutions filings for Q2 2026.
Security key
09060U606
13F reference period
Q2 2026
13F holders
21
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
BCDA full holder history
BioCardia, Inc. SEC filings
BioCardia, Inc. company facts
BioCardia, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09060U606:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
BCDA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Lincoln Alternative Strategies LLC | 7.5% | $1,560,000 | 800,000 | Lincoln Alternative Strategies LLC | 19 Sep 2025 | |||
| SATTERFIELD THOMAS A JR | 9.9% | +21% | $1,356,010 | +$467,153 | 592,144 | +53% | Thomas A. Satterfield, Jr. | 30 Jun 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $1,086,499 | 557,179 | Mitchell P. Kopin | 18 Sep 2025 | |||
| Blank Andrew Scott | 5.5% | $848,672 | 278,253 | Blank Andrew Scott | 23 Apr 2025 |
As of 30 Jun 2026,
21
institutional investors reported holding
shares of
BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA).
This represents
12%
of the company’s total
outstanding shares.
1.33M
Full value: 1,333,351 · shares · 30 Jun 202611.17M
Full value: 11,165,912 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
12%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| CITIGROUP INC | 3.6% | 397,594 | 0% | $493,017 | |
| CM Management, LLC | 2.7% | 300,000 | +131% | 0.24% | $372,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1% | 124,591 | 0% | 0% | $154,493 |
| Pingora Partners LLC | 1.1% | 120,382 | +237% | 0.09% | $149,274 |
| UBS Group AG | 0.7% | 77,619 | 0% | $96,248 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.6% | 66,664 | -29% | 0% | $82,662 |
| VANGUARD FIDUCIARY TRUST CO | 0.59% | 66,270 | 0% | 0% | $82,175 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.35% | 38,809 | -0.05% | 0% | $48,123 |
| BROWN ADVISORY INC | 0.32% | 35,538 | 0% | 0% | $44,067 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.21% | 23,383 | +28% | 0% | $28,990 |
| CITADEL ADVISORS LLC | 0.21% | 22,956 | -64% | 0% | $28,465 |
| StoneX Group Inc. | 0.18% | 20,020 | 0% | $24,825 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.17% | 18,500 | 0% | $16,924 | |
| GSA CAPITAL PARTNERS LLP | 0.12% | 12,862 | 0% | $16,000 | |
| Tower Research Capital LLC (TRC) | 0.03% | 3,187 | +7% | 0% | $3,952 |
| MORGAN STANLEY | 0.03% | 3,105 | 0% | 0% | $3,850 |
| Allied Private Wealth LLC | 0.01% | 1,449 | 0% | 0% | $1,398 |
| Global Retirement Partners, LLC | 0% | 411 | 0% | 0% | $510 |
| SBI Securities Co., Ltd. | 0% | 9 | 0% | 0% | $11 |
| Caitong International Asset Management Co., Ltd | 0% | 1 | 0% | $1 | |
| OSAIC HOLDINGS, INC. | 0% | 1 | 0% | 0% | $1 |
| Vanguard Global Advisers, LLC | 0% | 0 | -100% | $0 | |
| XTX Topco Ltd | 0% | 0 | -100% | $0 | |
| Virtu Financial LLC | 0% | 0 | -100% | $0 | |
| TWO SIGMA SECURITIES, LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Headline period
Q2 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 65,343 | $66,082 | +$3,125 | $1.01 | 4 |
| 2026 Q2 | 1,333,351 | $1,646,986 | +$795,557 | $1.24 | 21 |
| 2026 Q1 | 686,585 | $831,135 | -$26,108 | $1.21 | 18 |
| 2025 Q4 | 649,615 | $812,287 | +$277,290 | $1.25 | 20 |
| 2025 Q3 | 427,093 | $551,879 | +$144,113 | $1.29 | 18 |
| 2025 Q2 | 304,344 | $593,207 | +$114,077 | $1.95 | 16 |
| 2025 Q1 | 245,413 | $623,766 | +$308,212 | $2.54 | 12 |
| 2024 Q4 | 124,849 | $272,169 | +$50,907 | $2.18 | 13 |
| 2024 Q3 | 101,482 | $316,622 | +$81,316 | $3.12 | 9 |
| 2024 Q2 | 75,419 | $223,995 | +$223,995 | $2.97 | 8 |